# A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects

> **NCT02083627** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 25 (actual)

## Conditions studied

- Drug-Drug Interaction (DDI)
- Intestinal Absorption
- Healthy Subjects
- Pharmacokinetics of Rosuvastatin
- Pharmacokinetics of Fidaxomicin

## Interventions

- **DRUG:** rosuvastatin
- **DRUG:** fidaxomicin

## Key facts

- **NCT ID:** NCT02083627
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083627, "A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02083627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*